Do not use in horses suffering from gastrointestinal disorders such as irritation or haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Do not use in horses less than 6 weeks of age.
Special precautions for use
Special precautions for use in in the target species
Avoid use in any dehydrated, hypovolaemic or hypotensive animals, as there is a potential risk of renal toxicity.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) should avoid contact with the veterinary medicinal product.
In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
This veterinary medicinal product can cause eye irritation. In case of contact with the eyes, immediately rinse thoroughly with water.
Adverse events
Horses:
Very rare (<1 animal / 10,000 animals treated, including isolated reports): | Diarrhoea1, abdominal pain, colitis Appetite loss, lethargy Urticaria, anaphylactoid reaction2 |
Use during pregnancy, lactation or lay
Pregnancy and lactation:
Laboratory studies in cattle have not provided any evidence for teratogenic, foetotoxic, or maternotoxic effects. However, no data have been generated in horses.
Do not use in pregnant or lactating mares.
Interaction with other medicinal products and other forms of interaction
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.
Symptoms of overdose (and where applicable, emergency procedures and antidotes)
In the case of overdose symptomatic treatment should be initiated.
Withdrawal periods
Meat and offal: 3 days.
Not authorised to use in horses producing milk for human consumption.